FDHT precursor
Precursor for [¹⁸F]FDHT (16β-[¹⁸F]fluoro-5α-dihydrotestosterone)
16α-[[(trifluoromethyl)sulfonyl]oxy]-3,3-(ethylenedioxy)androstan-17-one; [¹⁸F]FDHT precursor
CA index name: Androstane-3,17-dione, 16-[[(trifluoromethyl)sulfonyl]oxy]-, cyclic 3-(1,2-ethanediyl acetal), (5α,16α)-
Quality
Research Chemical
Characteristics
Molar mass 480.54
CAS RN [141664-05-3]
Purity ≥ 95 %
- Colorless to off-white solid
Certificates
CoA: appearance, ¹H NMR spectrum
Literature
Liu A. et al. Fluorine-18-Labeled Androgens: Radiochemical Synthesis and Tissue Distribution Studies on Six fluorine-Substituted Androgens, Potential Imaging Agents for Prostatic Cancer. J. Nucl. Med. 1992, 33, 724–734.
Zhou D. et al. Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16α-[¹⁸F]fluoroestradiol (FES), [¹⁸F]fluoro furanylnorprogesterone (FFNP), and 16β-[¹⁸F]fluoro-5α-dihydrotestosterone (FDHT)as radiopharmaceuticals. J. Label. Compd. Radiopharm. 2014, 5, 371–377 DOI: 10.1002/jlcr.3191
Dehdashti F. et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur. J. Nucl. Med. Mol. Imaging 2005, 32, 344–350.
Add to inquiry
Product | Product No. | Filling amount | Quantity | ||
---|---|---|---|---|---|
/products/small-molecules-and-peptides/chemical/52226fe0-b267-49f5-9b9f-cbccb85ce7a9 | Precursor | Product No.: 1916 |